The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
AACR 2024 | Monoclonal B-cell lymphocytosis: a disease to be (or not to be)
Paolo Ghia, MD, Università Vita-Salute San Raffaele, Milan, Italy, briefly discusses monoclonal B-cell lymphocytosis (MBL), a precursor condition to chronic lymphocytic leukemia (CLL), and highlights the potential value of early interception to prevent disease progression. This interview took place at the American Association for Cancer Research (AACR) Annual Meeting 2024 in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
